MEDTRONIC HEART VALVES DIVISION ENVEO R DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
|
Back to Search Results |
|
Model Number ENVEOR-N |
Device Problems
Difficult or Delayed Positioning (1157); Device Dislodged or Dislocated (2923); Patient Device Interaction Problem (4001)
|
Patient Problem
Hematoma (1884)
|
Event Date 06/28/2018 |
Event Type
malfunction
|
Manufacturer Narrative
|
Continuation of d10: product id {evolutpro-29}; product lot/serial number (b)(6).Product type: {transcatheter aortic valve (tavr)}; implant date {na}; explant date {na} product id {ls-mdt2-2629}; product lot/serial number (b)(6).Product type: {compression loading system (cls)}; implant date {na}; explant date {na} product id {edwards}; product lot/serial number {unknown}; product type: {transcatheter aortic valve (tavr)}; implant date (b)(6) 2018 explant date {na}.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Medtronic received information that during the implant of this transcatheter bioprosthetic valve, the valve was recaptured three times for repositioning.After the point of no return, the valve dislodged towards the left ventricular outflow tract (lvot) despite tension regulation and pacing.It was reported that it was most likely due to the traction of the system by calcification and the tortuosity of the iliac vessel.The valve was not implanted and a non-medtronic valve was implanted.No adverse patient effects were reported.Additional information was reported that following the attempted implant of this transcatheter bioprosthetic valve and the implant of a non-medtronic valve, a hematoma of the left groin was identified.Minimal drop in hemoglobin levels were observed and no transfusion was required.The only treatment for the hematoma was a pressure bandage.Per the physician, the hematoma was not related to any medtronic device, but was related to the procedure.The hematoma resolved two days after onset.No adverse patient effects were reported.
|
|
Search Alerts/Recalls
|
|
|